Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 606-440-5 | CAS number: 201214-53-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Protocol approval date: 18 June 2001 - Report approval date: 18 October 2001
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: The study report did contain a reference to an international guideline with sufficient details but not totally GLP compliant. The study was performed according to SOP in a laboratory that conforms to GLP, but the report was not audited by the QAU.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 001
- Report date:
- 2001
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- Buehler test
- Principles of method if other than guideline:
- Also in accordance with the Guidelines published in the European Community Gazette (L383A, 29 December 1992).
- GLP compliance:
- no
- Remarks:
- Study performed according to SOP in a laboratory that conforms to GLP, but report not audited by the QAU
- Type of study:
- Buehler test
- Justification for non-LLNA method:
- Study was performed 2001, which is before the OECD guideline for the LLNA method was adopted (2002).
Test material
- Reference substance name:
- Iodomesac
- IUPAC Name:
- Iodomesac
- Reference substance name:
- Methyl 4-(acetylamino)-5-iodo-2-methoxybenzoate
- IUPAC Name:
- Methyl 4-(acetylamino)-5-iodo-2-methoxybenzoate
- Reference substance name:
- methyl 4-acetamido-5-iodo-2-methoxybenzoate
- EC Number:
- 606-440-5
- Cas Number:
- 201214-53-1
- Molecular formula:
- C11H12INO4
- IUPAC Name:
- methyl 4-acetamido-5-iodo-2-methoxybenzoate
- Details on test material:
- - Test compound (batch No.) Iodomesac (1S00004)
- Route of administration Cutaneous (occlusive bandage)
- Formulation Powder form suspended in petrolatum just before treatment
- Expiration date of the lot/batch: 15/05/2001
- A certificate of analysis is included in the report.
Constituent 1
Constituent 2
Constituent 3
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Hartley
- Sex:
- male
- Details on test animals and environmental conditions:
- Supplier: Charles River France, Saint-Aubin lès Elbeuf, 76410 Cléon, France
Age and body weight at initiation of treatment: Approximately 8 weeks and 530 g ± 100 g
Environment and husbandry:
- Housed in wire mesh bottomed, stainless steel cages; space allocated at initiation of treatment: 2898 cm² x 20 cm (4 animals/cage maximum).
- Temperature: 22 ± 2 ° C
- Relative humidity: 40-70%
- Air flow: 10-12 changes/hour without recirculation
- Light cycle: 12/24 hours
Diet and water:
- Diet: complete commercial rodent diet (re. 114C - 4.5 mm - U.A.R.) ad libitum.
- Water supply: free access to tap water through automatic waterers.
Pre-treatment procedures:
- Stabilisation: at least 2 weeks before beginning treatment.
- Number of animals: 50 males.
- Number of animals/group: 20 males (main study) or 5 males (preliminary assay).
- Allocation to experimental groups : at random.
- Identification: ear tattoo with the identity number (main study) or mark with felt-tip pen (preliminary assay).
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- petrolatum
- Concentration / amount:
- See below.
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- petrolatum
- Concentration / amount:
- See below.
- No. of animals per dose:
- Preliminary assay: 5 males
Final assay: 20 males
Preliminary assay:
Concentration of Iodomesac in Petrolatum:
Occlusive bandage (6 h) (0.2 mL)
No. of animals Right flank Left flank
5 10% 5%
5 30% 20%
Final assay:
Control group (10): Induction phase: Petrolatum; Challenge 10% Iodomesac in petrolatum on the right flank
Treated group Induction phase (10): 30% Iodomesac in petrolatum; Challenge 10% Iodomesac in petrolatum on the right flank
The left flank was not treated. - Details on study design:
- PRELIMINARY ASSAY:
determination of MNIC (Maximum Non-Irritant Concentration) and MIC (Minimal Irritant Concentration)
Dosing frequency: once. All dosages and concentrations are expressed in terms of the material received.
Animals concerned: .
- 2 groups of 5 additional guinea-pigs
- the hind flanks of each animal are sheared.
Method:
- Treatment: application under occlusion for 6 hours of an approximately 5 cm² patch (type filter paper Whatman GF/C) soaked with 0.2 ml test substance diluted at various concentrations in its vehicle.
- Frequency of observations: local reactions are recorded 24 and 48 hours after removing the occlusive bandage.
- Concentration retained: minimal concentration, which induces a reaction (MIC - Induction phase) and maximum concentration, which does not induce any reaction (MNIC - challenge phase).
FINAL ASSAY:
1. First period: sensitization induction phase
Animals concerned:
- all animals
- the right flank anterior part of each animal is sheared.
Method:
- Treated group: Days 1, 8 and 15, application under occlusion for 6 hours of an approximately 5 cm² patch (type filter paper Whatman GF/C) soaked with 0.2 ml test substance at a 30% (MIC) concentration in its vehicle. The left flank is not treated.
- Control group: the control group receives the vehicle according to the same procedure.
Animals recovery for 2 weeks approximately.
2. Second period: challenge phase
Animals concerned:
- all animals
- the posterior right and left dorsal areas of each animal are sheared.
Method:
- Day 28:
application under occlusion for 6 hours on the right flank of an approxiately 5 cm² patch (type filter paper Whatman GF/C) soaked with 0.2 ml test
substance at a 10% (MNIC) concentration in its vehicle. The left flank is not treated.
- Frequency of observations: local reactions are recorded 24 and 48 hours after removing the occlusive bandage.
ASSESSMENT OF CUTANEOUS SENSITIZATION
Method:
- Assessment according to Buelher’s technique.
- Results are noted for each animal on the basis of skin reactions, in order to determine the reactivity specific to the allergen.
Erythema
0 No reaction
1 Slight scattered redness
2 Moderate diffuse redness
3 Marked swollen redness
Edema
0 No edema
1 Very slight edema (barely perceptible)
2 Slight edema (edges of area well-defined by definite raising)
3 Moderate edema (raised approximately 1 mm)
4 Severe edema (raised more than 1 mm and extending beyond the area
of exposure)
Determination of the allergenicity degree: on the basis of the number of animals presenting a reaction.
Five degrees are defined according to the following scale:
Percentage of animals presenting a reaction / Allergenicity degree
0 - 8 I
9 - 28 II
29 - 64 III
65 - 80 IV
81 - 100 V
CLINICAL EXAMINATIONS
Clinical signs and mortality:
- Frequency: once daily, 5 days/7, throughout the study.
- Animals concerned: all animals.
- Clinical signs: date of onset and progression are recorded. Visual observation.
- Mortality: post-mortem examination of decedents or of animals killed in extremis.
Body weight:
- Frequency: prior to treatment, then weekly.
- Animals concerned: all animals.
- Parameter: body weight (g).
Necropsy:
In case of positive reaction requiring deeper interpretation:
- PathData number: 30078.
- Necropsy day: on day 30.
Animals concerned: all animals, sacrificed by exsanguination while under general anesthesia with pentobarbital sodium, 1 ml/kg, I.P.
Macroscopy:
- cavities, organs and/or tissues to be examined: Right and Left skin and subcutaneous tissues
- organs and tissues taken: Right and Left skin and subcutaneous tissues
Light microscopy:
- organs and tissues examined: Right and Left skin and subcutaneous tissues
When the interpretation of the results does not require necropsy, the animals are euthanazied with no organ sampling.
In case of mortality during the study, samples are taken to justify the cause of death.
Findings are noted in the necropsy book.
The following samples are taken:
- macroscopic changes
- liver
- kidneys
- heart
- lungs - Challenge controls:
- Yes, see above.
- Positive control substance(s):
- not required
Results and discussion
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- other: Irritancy
- Hours after challenge:
- 6
- Group:
- test chemical
- Dose level:
- right: 10 & 30 %; left: 5 & 20 %.
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- There was no irritant concentration. Based on that result and after solubility assay, the following standard concentrations were retained: 10% for MNIC and 30% for MIC.
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: other: Irritancy. . Hours after challenge: 6.0. Group: test group. Dose level: right: 10 & 30 %; left: 5 & 20 %.. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: There was no irritant concentration. Based on that result and after solubility assay, the following standard concentrations were retained: 10% for MNIC and 30% for MIC..
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 30 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- No treatment-related changes.
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 30 %. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: No treatment-related changes. .
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 30 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- No treatment-related changes.
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 30 %. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: No treatment-related changes. .
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Iodomesac had no cutaneous sensitizing effect in the guinea pig: no reaction was observed in either the sensitized group or the nonsensitized group and no treatment-related changes were observed for clinical signs and body weight (weekly).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.